Re: a multicenter phase II study of gemcitabine and oxaliplatin for malignant pleural mesothelioma.
Vogelzang
Nicholas J
NJ
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003841:Deoxycytidine / Q000008:administration & dosage / Q000031:analogs & derivatives*; D016527:Drug Costs; D023381:Endpoint Determination; D006801:Humans; D008654:Mesothelioma / Q000188:drug therapy*; D009944:Organoplatinum Compounds / Q000008:administration & dosage; D000077150:Oxaliplatin; D010347:Patient Care Planning; D010997:Pleural Neoplasms / Q000188:drug therapy*; D016896:Treatment Outcome; D000093542:Gemcitabine
D009944:Organoplatinum Compounds; D000077150:Oxaliplatin; D003841:Deoxycytidine; D000093542:Gemcitabine